Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kultevat is an industrial biotechnology company focused on the sustainable production of high-quality natural rubber and mixed sugar feedstocks. The company utilizes the Russian Dandelion (Taraxacum kok-saghyz) as a renewable source for rubber, providing an alternative to the traditional Hevea brasiliensis tree. Kultevat's technology encompasses advanced plant breeding, cultivation, and proprietary extraction processes to produce rubber that is chemically identical to conventional natural rubber but with hypoallergenic properties. Headquartered in St. Louis, the company serves the tire, medical, and industrial markets by securing a domestic and sustainable supply chain for rubber. Their approach addresses both environmental sustainability and the need for high-performance materials in healthcare and transportation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kultevat.